NDAORALTABLET
Approved
Feb 2012
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
17
Mechanism of Action
Progestational Hormone Receptor Antagonists
Pharmacologic Class:
Progestin Antagonist
Clinical Trials (5)
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
Started Oct 2023
201 enrolled
Metastatic Breast Cancer
Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST)
Started Mar 2023
1,113 enrolled
HypercortisolismDiabetes Mellitus, Type 2
Mifepristone Dynamic Testing for Diagnosis for Central Adrenal Insufficiency
Started May 2021
3 enrolled
Central Adrenal InsufficiencyMifepristone
Retrospective Chart Review Study of Pediatric Patients Treated With Korlym for Cushing Syndrome
Started Sep 2017
2 enrolled
HypercortisolismCushing Syndrome
Crossover Drug-Drug Interaction Study to Determine Effects of Cytochrome P450 3A on Exposure to Mifepristone and Its Metabolites
Started Aug 2017
48 enrolled
Healthy
Loss of Exclusivity
LOE Date
Aug 22, 2038
151 months away
Patent Expiry
Aug 22, 2038